YungShin Global Holding Corporation

3705

TW0003705000

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-06-11 EDT			5-day change	1st Jan Change
53.6 ^TWD	-0.92%		-3.07%	+15.27%

05-10	YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-29	YungShin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Forward BioT Venture Capital announced that it expects to receive TWD 60 million in funding from YungShin Global Holding Corporation

November 08, 2022

Forward BioT Venture Capital announced that it will received TWD 60,000,000 in a round of funding on November 9, 2022. The transaction will include participation from new investor YungShin Global Holding Corporation.

Latest news about YungShin Global Holding Corporation

YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
YungShin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
YungShin Global Holding Corporation Announces Cash Dividend, Payable on July 17, 2024	03-27	CI
Yungshin Global Holding Corporation Announces Resignation of Fang-Hsin Lee as Chairperson of Carlsbad Technology, Inc, Effective April 1, 2024	03-08	CI
YungShin Global Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
YungShin Global Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
YungShin Global Holding Corporation Announces President Changes	23-08-09	CI
YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
YungShin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Yungshin Global Holding Corporation Announces Cash Dividend, Payable on July 13, 2023	23-03-29	CI
YungShin Global Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Forward BioT Venture Capital announced that it expects to receive TWD 60 million in funding from YungShin Global Holding Corporation	22-11-08	CI
YungShin Global Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09	CI
YungShin Global Holding Corporation agreed to acquire Yung Shin China Holding Co. Ltd and Yung Shin Pharmaceutical Ind. Co., Ltd.	22-06-29	CI
YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
YungShin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
YungShin Global Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI
Yungshin Global Holding Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-09	CI
Yungshin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Yungshin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-29	CI
Yungshin Global Holding Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-10	CI
Yungshin Global Holding Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Yungshin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-12	CI
Yungshin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-30	CI

Chart YungShin Global Holding Corporation

Duration

Period

Chart YungShin Global Holding Corporation

More charts

Company Profile

YungShin Global Holding Corp is a Taiwan-based company mainly engaged in the manufacture and sale of human pharmaceutical medicine and animal medicine. The Company mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The Company also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.

Sector

Pharmaceuticals

Calendar

2024-08-07 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
YUNGSHIN GLOBAL HOLDING CORPORATION	+15.27%	445M
ELI LILLY AND COMPANY	+48.79%	780B
NOVO NORDISK A/S	+41.76%	627B
MERCK & CO., INC.	+19.43%	334B
ABBVIE INC.	+7.18%	296B
ASTRAZENECA PLC	+17.60%	244B
ROCHE HOLDING AG	-0.41%	217B
NOVARTIS AG	+11.54%	214B
AMGEN INC.	+4.53%	161B
PFIZER, INC.	-3.92%	159B